These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 360247)

  • 61. A controlled replication of the effectiveness of diphenylhydantoin in reducing irritability and anxiety in selected neurotic outpatients.
    Stephens JH; Shaffer JW
    J Clin Pharmacol; 1973; 13(8):351-6. PubMed ID: 4579971
    [No Abstract]   [Full Text] [Related]  

  • 62. Thioridazine in the treatment of depressive patients.
    de Jonghe FE; Schalken HF; van der Helm HJ
    Acta Psychiatr Scand; 1976 Apr; 53(4):271-6. PubMed ID: 775889
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clomacran in anxious neurotic outpatients: a controlled study.
    Rickels K; Perloff M; Perez LA; Pereira-Ogan JA; Kelly EA; Hesbacher PT
    J Clin Pharmacol New Drugs; 1972 Jan; 12(1):46-53. PubMed ID: 4550225
    [No Abstract]   [Full Text] [Related]  

  • 64. A comparison of the effects of prazepam, chlordiazepoxide, and placebo in the short-term treatment of convalescing alcoholics.
    Shaffer JW; Yeganeh ML; Foxwell NH; Kurland AA
    J Clin Pharmacol J New Drugs; 1968; 8(6):392-9. PubMed ID: 4883786
    [No Abstract]   [Full Text] [Related]  

  • 65. The subjective experience of the research patient: an investigation of psychiatric outpatients' reactions to the research treatment situation.
    Park LC; Slaughter R; Covi L; Kniffin HG
    J Nerv Ment Dis; 1966 Sep; 143(3):199-206. PubMed ID: 5335078
    [No Abstract]   [Full Text] [Related]  

  • 66. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A double blind comparative study of mianserin and a fixed combination of amitriptyline plus chlordiazepoxide.
    Dimitriou EC; Logothetis JA; Paschalidou M
    Adv Biochem Psychopharmacol; 1982; 32():213-22. PubMed ID: 7046365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Influence of doctors' and patients' attitudes in the treatment of neurotic illness.
    Wheatley D
    Lancet; 1967 Nov; 2(7526):1133-5. PubMed ID: 4168567
    [No Abstract]   [Full Text] [Related]  

  • 70. The treatment of severe anxiety in outpatients: a controlled study comparing chlordiazepoxide and chlorpromazine.
    Yamamoto J; Kline FM; Burgoyne RW
    Psychosomatics; 1973; 14(1):46-51. PubMed ID: 4605352
    [No Abstract]   [Full Text] [Related]  

  • 71. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 72. Coffee consumption, cigarette smoking and reporting of drowsiness in anxious patients treated with benzodiazepines or placebo.
    Downing RW; Rickels K
    Acta Psychiatr Scand; 1981 Nov; 64(5):398-408. PubMed ID: 7051756
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amytriptyline and chlordiazepoxide (Limbitrol) in depressive states in Nigerians--a double-blind study.
    Morakinyo VO
    Afr J Med Sci; 1970 Oct; 1(4):409-14. PubMed ID: 4940219
    [No Abstract]   [Full Text] [Related]  

  • 74. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ripazepam (CI-683): double-blind comparison with placebo in anxious patients.
    Schneyer JJ; Goodman LI; Borgen LA
    J Clin Pharmacol; 1976 Jul; 16(7):377-83. PubMed ID: 780378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical assessment of the safety and efficacy of lorazepam, a new benzodiazepine derivative, in the treatment of anxiety.
    Pinosky DG
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):24-9. PubMed ID: 30763
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Controlled clinical trial of parsalmide in patients with predominantly neuro-anxiety syndromes. Comparison with chlordiazepoxide].
    Poli V
    Minerva Med; 1976 Oct; 67(52):3409-12. PubMed ID: 11424
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oxazepam-protriptyline: a double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):825-38. PubMed ID: 813948
    [No Abstract]   [Full Text] [Related]  

  • 79. Efficacy of imipramine and chlordiazepoxide in depressive and anxiety disorders questioned.
    Welner J
    Arch Gen Psychiatry; 1987 Jan; 44(1):97-8. PubMed ID: 3800590
    [No Abstract]   [Full Text] [Related]  

  • 80. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.